| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-02 | FY 2024
FILED 2024-12-27 | FY 2023
FILED 2023-12-29 |
|---|---|---|---|
| Revenue (Total Sales) | $681.6M | $565.8M | $510.1M |
| YoY Revenue Growth % | +20.5% | +10.9% | — |
| Gross Profit | $255.7M | $202.8M | — |
| Gross Margin % | 37.5% | 35.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $44.1M | $31.4M | $22.1M |
| Operating Margin % | 6.5% | 5.5% | 4.3% |
| Net Income (GAAP) | $52.6M | $22.6M | $10.9M |
| EBITDA (Normalized) | $51.7M | $38.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $80.1M | $72.1M | $39.2M |
| Capital Expenditures (CapEx) | $9.4M | $8.4M | — |
| Free Cash Flow (FCF) | $70.7M | $63.7M | $39.2M |
| FCF Margin % | 10.4% | 11.3% | 7.7% |
| Return on Invested Capital (ROIC %) | 12.2% | 10.3% | — |
| Cash & Short-Term Equivalents | $65.9M | $74.2M | — |
| Total Debt (Short + Long Term) | $46.0M | $79.3M | — |
| Total Stockholders' Equity | $304.9M | $234.3M | — |